Farallon Capital Management’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,648,696
| Closed | -$17.7M | – | 104 |
|
|
2017
Q2 | $17.7M | Hold |
2,648,696
| – | – | 0.18% | 57 |
|
|
2017
Q1 | $10.3M | Hold |
2,648,696
| – | – | 0.11% | 59 |
|
|
2016
Q4 | $9.72M | Hold |
2,648,696
| – | – | 0.11% | 55 |
|
|
2016
Q3 | $11M | Hold |
2,648,696
| – | – | 0.16% | 48 |
|
|
2016
Q2 | $12.3M | Hold |
2,648,696
| – | – | 0.17% | 44 |
|
|
2016
Q1 | $8.74M | Buy |
2,648,696
+145,000
| +6% | +$479K | 0.08% | 55 |
|
|
2015
Q4 | $8.54M | Hold |
2,503,696
| – | – | 0.08% | 50 |
|
|
2015
Q3 | $9.11M | Buy |
2,503,696
+3,700
| +0.1% | +$13.5K | 0.12% | 57 |
|
|
2015
Q2 | $12.4M | Hold |
2,499,996
| – | – | 0.17% | 62 |
|
|
2015
Q1 | $20.1M | Buy |
+2,499,996
| New | +$20.1M | 0.29% | 54 |
|